Pharmaids Pharmaceuticals Limited — Quarterly Results & Earnings

₹27.67

-6.17%

Profit Growth YoY-171.97%Latest quarter

Sales Growth YoY64.31%Latest quarter

Sales CAGR 5YN/A5 year compound

Profit CAGR 5YN/A5 year compound

📋

Quarterly Performance

YoY Profit Growth-171.97%

🔴 Significant decline

YoY Sales Growth+64.31%

🔥 Exceptional growth

OPM 5Y Average

Operating profit margin

N/A

EPS Growth 5Y

N/A

Interest Coverage

Higher = safer debt servicing

-5.17

ROE

-16.29%

ROCE

-17.43%

💡

Growth Analysis

Pharmaids Pharmaceuticals Limited reported YoY profit growth of -171.97% and revenue growth of 64.31% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at N/A and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Pharmaids Pharmaceuticals Limited

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.